Career conversation 41: shattering roadblocks to pave the way for advancement Extensive research reveals the obstacles women face on their path to career advancement, including workplace exclusion, bias in project […]
Breaking down barriers in support of patients with rare diseases There are over 7,000 rare diseases and one in 10 worldwide have a rare disease. Over 675 diseases have some […]
The clinical trial diversity puzzle: how can the industry do better? The industry has faced the lack of clinical trial diversity head-on by working to improve access to clinical trials. […]
Importance of early integrated evidence strategy for cell & gene therapies The healthcare ecosystem is a complex network of stakeholders that requires a focused engagement strategy to navigate the evolving […]
With a focus on leadership, discussion themes will include building confidence, how to find your sponsor or mentor, and thriving and uplifting.
This webinar will cover key considerations for developing strategic and optimized global multiregional clinical trials. Register to learn how addressing regulatory, pricing, market access and commercial strategy considerations early in the clinical development planning and design process can help support future commercial success for APAC-developed assets on the global stage.
Learn about moving the MSL-KOL relationships from perfunctory to powerful. Join the featured speakers in reviewing the importance of KOL Identification and management and learn how to leverage the right technology and tools to create a quality engagement.
Attendees will learn barriers and effective strategies to mirroring the patient community make-up in rare disease clinical trials; challenges that rare disease patient organizations are tackling to improve diversity, equity and inclusion (DE&I) in their own communities; and consequences of getting it ‘wrong’ in the clinical stage and beyond.
When seamlessly collaborating with partners on the same cloud-based safety solution, sponsors have real-time visibility and control while driving more efficient and faster processes. Easily scaling with more studies or data, modern pharmacovigilance (PV) applications are intuitive and designed for teams to work together globally.
Join this webinar session for case study examples that demonstrate how innovative pharma marketers are utilizing social networks as a force for good to cultivate lasting consumer relationships and improve patient outcomes. Learn what’s working – and what pitfalls to avoid – in today’s rapidly evolving digital landscape.
